← The Wire
INONasdaq
INOVIO PHARMACEUTICALS, INC.
Pharmaceutical Preparations · DE · CIK 1055726
INOVIO Pharmaceuticals develops DNA medicines for HPV, cancer, and infectious diseases
⚡ Elevated coverage
$91M
Market cap
$1.12
Last close
+1.8%
1D
+0.9%
5D
1.7M
Volume
Price · last 39 sessions-1.8%
May 4L $1.07 · H $1.46Jun 29
323
Total filings
May 20, 2026
Last filing
12/31
Fiscal year end
8-KBylaw Amendment · Shareholder VoteMay 20, 20268-KResults of OperationsMay 13, 202610-Q10-QMay 13, 2026DEF 14ADEF 14AApr 7, 20268-KMaterial Agreement · Company UpdateApr 6, 2026424B5424B5Apr 2, 20268-KCompany UpdateApr 2, 2026424B5424B5Apr 2, 20268-KResults of OperationsMar 12, 202610-K10-KMar 12, 2026424B5424B5Jan 27, 20268-KMaterial Agreement · Security-Holder RightsJan 27, 20268-KReg FD Disclosure · Company UpdateDec 29, 20258-KMaterial Agreement · Company UpdateNov 12, 2025424B5424B5Nov 12, 2025424B5424B5Nov 12, 20258-KResults of OperationsNov 10, 202510-Q10-QNov 10, 20258-KResults of OperationsAug 12, 202510-Q10-QAug 12, 20258-KMaterial Agreement · Company UpdateJul 7, 2025424B5424B5Jul 3, 2025424B5424B5Jul 2, 20258-KShareholder VoteMay 22, 20258-KResults of OperationsMay 13, 202510-Q10-QMay 13, 2025DEF 14ADEF 14AApr 7, 20258-KResults of OperationsMar 18, 202510-K10-KMar 18, 20258-KMaterial Agreement · Company UpdateDec 16, 2024424B5424B5Dec 13, 2024424B5424B5Dec 12, 20248-KResults of OperationsNov 14, 202410-Q10-QNov 14, 2024SC 13GSC 13GNov 8, 2024SC 13GSC 13GOct 22, 2024424B5424B5Aug 13, 20248-KMaterial AgreementAug 13, 20248-KResults of OperationsAug 8, 202410-Q10-QAug 8, 20248-KExecutive Change · Shareholder VoteMay 28, 20248-KResults of OperationsMay 13, 202410-Q10-QMay 13, 2024SC 13GSC 13GApr 26, 20248-KMaterial Agreement · Company UpdateApr 17, 2024424B5424B5Apr 17, 2024DEF 14ADEF 14AApr 11, 202410-K10-KMar 6, 20248-KBylaw AmendmentJan 25, 20248-KShareholder VoteJan 12, 2024DEF 14ADEF 14ANov 28, 20238-KResults of OperationsNov 9, 202310-Q10-QNov 9, 20238-KDelisting NoticeNov 2, 20238-KReg FD Disclosure · Company UpdateOct 10, 20238-KResults of OperationsAug 9, 202310-Q10-QAug 9, 20238-KExit / Disposal CostsAug 1, 20238-KReg FD DisclosureJun 23, 20238-KExecutive Change · Shareholder VoteMay 18, 20238-KResults of OperationsMay 10, 202310-Q10-QMay 10, 2023DEFA14ADEFA14AMar 31, 2023DEF 14ADEF 14AMar 28, 202310-K10-KMar 1, 20238-KResults of OperationsMar 1, 20238-KExit / Disposal Costs · Reg FD DisclosureJan 31, 20238-KResults of OperationsNov 8, 202210-Q10-QNov 8, 20228-KResults of OperationsAug 9, 202210-Q10-QAug 9, 20228-KExit / Disposal Costs · Reg FD DisclosureJul 19, 20228-KExecutive Change · Shareholder VoteMay 17, 2022DEFA14ADEFA14AMay 11, 20228-KExecutive Change · Results of OperationsMay 10, 202210-Q10-QMay 10, 2022DEF 14ADEF 14AMar 25, 202210-K10-KMar 1, 2022424B5424B5Nov 9, 202110-Q10-QNov 9, 2021
In the News
⚡ Elevated coverageCoverage (30d): 4 reputable articles.
MarketWatchInovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors despite daily gains3d agoMarketWatchInovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors24d agoMarketWatchInovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors despite daily gains25d agoMarketWatchInovio Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors27d ago
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance